Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here